Several studies have analyzed the role of IL‐17 in various inflammatory diseases, finding elevated levels in patients with rheumatoid arthritis, spondyloarthritis, inflammatory bowel disease, psoriasis, and periodontitis [35, 36]. Here, IL17A is linked to inflammatory bowel disease.